Sub menu

 

 

Update to listed medicine ingredients in June 2026

Published

Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026

Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026, which commenced on 12 June 2026. This determination replaces the previous instrument, the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2026.

This instrument is updated frequently and there may be a more recent version of the instrument. Ensure you are accessing the current version of the instrument through the Therapeutic Goods Determination page.

A complete list of the 5 changed ingredients is below.

Changed ingredients

Substance nameChange
Xanthium sibiricumChange
Xanthium strumariumChange
theanineChange
oxaceprolAddition
Lactococcus lactis subsp. lactisAddition
Featured in

Related content

  • Update to listed medicine ingredients in March 2026

    Regulatory decision notices
    Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2026, which commenced on 1 March 2026.

  • Update to listed medicine ingredients in June 2024

    Regulatory decision notices
    Find out how listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2024, which commenced on 14 June 2024.